Agenus Reports First Quarter 2014 Financial Results
[Business Wire] – Agenus Inc. , an immuno-oncology company developing a portfolio of checkpoint modulators , heat shock protein vaccines and adjuvants, today announced its financi more
View todays social media effects on AGEN
View the latest stocks trending across Twitter. Click to view dashboard